Miransertib (ARQ 092) HCl

Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.
Supplier Selleck Chemicals
Product # S8339
Sku # S8339-5mg
Pricing 5mg, $147.00
Feedback